AXSM
Axsome Therapeutics, Inc.$207.33-9.48 (-4.38%)Prev Close$216.58·MCap$11.36B·P/E—·Vol418.4K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
23
$146.15M
◆
Net Activity
Net Seller
$146.15M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Axsome Therapeutics, Inc. (AXSM) has been exclusively selling, with 0 insider purchases totaling $0.00 and 23 insider sales totaling $146.15M. The most recent insider transaction was by Jacobson Mark L. (officer: Chief Operating Officer), who sold $2.09M worth of shares on Sep 3, 2026. Axsome Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $11.36B.
AXSM Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Jacobson Mark L. | officer: Chief Operating Officer | Sell | 10,000 | $208.65 | $2.09M | 0Exit |
| Aug 7, 2026 | TABUTEAU HERRIOT | director, 10 percent owner, officer: Chief Executive Officer | Sell | 49,664 | $212.19 | $10.54M | 7,229-87% |
| Jul 1, 2026 | TABUTEAU HERRIOT | director, 10 percent owner, officer: Chief Executive Officer | Sell | 49,666 | $240.25 | $11.93M | 7,229-87% |
| Jun 11, 2026 | JEFFS ROGER | director | Sell | 572 | $247.65 | $141.7K | 58,653 |
| Jun 10, 2026 | Mahony Susan | director | Sell | 600 | $241.70 | $145.0K | 1,129-35% |
| Jun 10, 2026 | Coleman Mark | director | Sell | 643 | $249.00 | $160.1K | 30,389 |
| Jun 9, 2026 | TABUTEAU HERRIOT | director, 10 percent owner, officer: Chief Executive Officer | Sell | 49,670 | $241.01 | $11.97M | 7,229-87% |
| Jun 9, 2026 | Pizzie Nick | officer: Chief Financial Officer | Sell | 33,000 | $240.09 | $7.92M | 42,867-43% |
| Jun 2, 2026 | Coleman Mark | director | Sell | 17,537 | $229.20 | $4.02M | 41,140-30% |
| May 5, 2026 | Jacobson Mark L. | officer: Chief Operating Officer | Sell | 4,750 | $227.95 | $1.08M | 0Exit |
| Apr 23, 2026 | Maizel Ari | officer: Chief Commercial Officer | Sell | 7,500 | $182.42 | $1.37M | 0Exit |
| Feb 27, 2026 | Coleman Mark | director | Sell | 25,000 | $161.11 | $4.03M | 47,140-35% |
| Feb 27, 2026 | Jacobson Mark L. | officer: Chief Operating Officer | Sell | 35,378 | $161.88 | $5.73M | 0Exit |
| Feb 2, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 32,410 | $185.60 | $6.02M | 0 |
| Jan 22, 2026 | Pizzie Nick | Chief Financial Officer | Sell | 12,000 | $187.92 | $2.26M | 0 |
| Jan 21, 2026 | Maizel Ari | Chief Commercial Officer | Sell | 7,500 | $184.44 | $1.38M | 0 |
| Jan 5, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 139,414 | $171.30 | $23.88M | 0 |
| Dec 31, 2025 | Saad Mark E | Director | Sell | 37,577 | $165.18 | $6.21M | 0 |
| Dec 2, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 79,973 | $145.66 | $11.65M | 0 |
| Nov 3, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 163,939 | $133.07 | $21.82M | 0 |
| Oct 6, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 45,384 | $119.38 | $5.42M | 0 |
| Sep 22, 2025 | Jacobson Mark L. | Chief Operating Officer | Sell | 10,000 | $115.96 | $1.16M | 0 |
| Sep 16, 2025 | Jacobson Mark L. | Chief Operating Officer | Sell | 45,783 | $114.48 | $5.24M | 0 |
| Sep 12, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 62,880 | $117.08 | $7.36M | 0 |
| Sep 8, 2025 | Coleman Mark | Director | Buy | 1,575 | $127.28 | $200.5K | 0 |
| Sep 5, 2025 | Saad Mark E | Director | Sell | 9,127 | $125.07 | $1.14M | 0 |
| Sep 2, 2025 | JEFFS ROGER | Director | Sell | 13,464 | $123.68 | $1.67M | 0 |
| Aug 27, 2025 | JEFFS ROGER | Director | Sell | 60,000 | $121.72 | $7.30M | 0 |
| Aug 22, 2025 | JEFFS ROGER | Director | Sell | 36,694 | $120.05 | $4.41M | 0 |
| Jun 20, 2025 | Murdock Hunter R. | General Counsel | Sell | 13,514 | $101.42 | $1.37M | 0 |
| Jun 16, 2025 | Murdock Hunter R. | General Counsel | Sell | 22,500 | $101.19 | $2.28M | 0 |
| Jun 9, 2025 | Jacobson Mark L. | Chief Operating Officer | Sell | 25,000 | $110.44 | $2.76M | 0 |
| May 27, 2025 | Coleman Mark | Director | Sell | 7,500 | $104.45 | $783.4K | 0 |
| May 27, 2025 | Jacobson Mark L. | Chief Operating Officer | Sell | 40,673 | $104.07 | $4.23M | 0 |
| May 20, 2025 | Coleman Mark | Director | Sell | 3,000 | $107.49 | $322.5K | 0 |
| Feb 13, 2025 | Pizzie Nick | Chief Financial Officer | Sell | 15,000 | $130.10 | $1.95M | 0 |
| Aug 9, 2024 | Jacobson Mark L. | Chief Operating Officer | Sell | 47,739 | $84.26 | $4.02M | 0 |
| May 29, 2024 | Jacobson Mark L. | Chief Operating Officer | Sell | 7,910 | $74.31 | $587.8K | 0 |
| May 28, 2024 | Coleman Mark | Director | Sell | 10,497 | $75.17 | $789.1K | 0 |
| Apr 1, 2024 | Jacobson Mark L. | Chief Operating Officer | Sell | 24,662 | $77.24 | $1.90M | 0 |
| Mar 14, 2024 | JEFFS ROGER | Director | Sell | 32,323 | $69.84 | $2.26M | 0 |
| Sep 15, 2023 | Coleman Mark | Director | Sell | 29,588 | $75.18 | $2.22M | 0 |
| Nov 19, 2021 | JEFFS ROGER | Director | Buy | 3,950 | $37.30 | $147.3K | 0 |
| Nov 18, 2021 | Coleman Mark | Director | Buy | 1,430 | $35.09 | $50.2K | 0 |
| Nov 18, 2021 | Pizzie Nick | CHIEF FINANCIAL OFFICER | Buy | 955 | $35.26 | $33.7K | 0 |
| Nov 17, 2021 | Saad Mark E | Director | Buy | 3,200 | $34.53 | $110.5K | 0 |
| May 12, 2021 | Coleman Mark | Director | Buy | 500 | $58.15 | $29.1K | 0 |
AXSM Insider Buying Activity
The following table shows recent insider purchases of Axsome Therapeutics, Inc. (AXSM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 8, 2025 | Coleman Mark | Director | Buy | 1,575 | $127.28 | $200.5K | 0 |
| Nov 19, 2021 | JEFFS ROGER | Director | Buy | 3,950 | $37.30 | $147.3K | 0 |
| Nov 18, 2021 | Coleman Mark | Director | Buy | 1,430 | $35.09 | $50.2K | 0 |
| Nov 18, 2021 | Pizzie Nick | CHIEF FINANCIAL OFFICER | Buy | 955 | $35.26 | $33.7K | 0 |
| Nov 17, 2021 | Saad Mark E | Director | Buy | 3,200 | $34.53 | $110.5K | 0 |
| May 12, 2021 | Coleman Mark | Director | Buy | 500 | $58.15 | $29.1K | 0 |
AXSM Insider Selling Activity
The following table shows recent insider sales of Axsome Therapeutics, Inc. (AXSM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Jacobson Mark L. | officer: Chief Operating Officer | Sell | 10,000 | $208.65 | $2.09M | 0Exit |
| Aug 7, 2026 | TABUTEAU HERRIOT | director, 10 percent owner, officer: Chief Executive Officer | Sell | 49,664 | $212.19 | $10.54M | 7,229-87% |
| Jul 1, 2026 | TABUTEAU HERRIOT | director, 10 percent owner, officer: Chief Executive Officer | Sell | 49,666 | $240.25 | $11.93M | 7,229-87% |
| Jun 11, 2026 | JEFFS ROGER | director | Sell | 572 | $247.65 | $141.7K | 58,653 |
| Jun 10, 2026 | Mahony Susan | director | Sell | 600 | $241.70 | $145.0K | 1,129-35% |
| Jun 10, 2026 | Coleman Mark | director | Sell | 643 | $249.00 | $160.1K | 30,389 |
| Jun 9, 2026 | TABUTEAU HERRIOT | director, 10 percent owner, officer: Chief Executive Officer | Sell | 49,670 | $241.01 | $11.97M | 7,229-87% |
| Jun 9, 2026 | Pizzie Nick | officer: Chief Financial Officer | Sell | 33,000 | $240.09 | $7.92M | 42,867-43% |
| Jun 2, 2026 | Coleman Mark | director | Sell | 17,537 | $229.20 | $4.02M | 41,140-30% |
| May 5, 2026 | Jacobson Mark L. | officer: Chief Operating Officer | Sell | 4,750 | $227.95 | $1.08M | 0Exit |
| Apr 23, 2026 | Maizel Ari | officer: Chief Commercial Officer | Sell | 7,500 | $182.42 | $1.37M | 0Exit |
| Feb 27, 2026 | Coleman Mark | director | Sell | 25,000 | $161.11 | $4.03M | 47,140-35% |
| Feb 27, 2026 | Jacobson Mark L. | officer: Chief Operating Officer | Sell | 35,378 | $161.88 | $5.73M | 0Exit |
| Feb 2, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 32,410 | $185.60 | $6.02M | 0 |
| Jan 22, 2026 | Pizzie Nick | Chief Financial Officer | Sell | 12,000 | $187.92 | $2.26M | 0 |
| Jan 21, 2026 | Maizel Ari | Chief Commercial Officer | Sell | 7,500 | $184.44 | $1.38M | 0 |
| Jan 5, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 139,414 | $171.30 | $23.88M | 0 |
| Dec 31, 2025 | Saad Mark E | Director | Sell | 37,577 | $165.18 | $6.21M | 0 |
| Dec 2, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 79,973 | $145.66 | $11.65M | 0 |
| Nov 3, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 163,939 | $133.07 | $21.82M | 0 |
| Oct 6, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 45,384 | $119.38 | $5.42M | 0 |
| Sep 22, 2025 | Jacobson Mark L. | Chief Operating Officer | Sell | 10,000 | $115.96 | $1.16M | 0 |
| Sep 16, 2025 | Jacobson Mark L. | Chief Operating Officer | Sell | 45,783 | $114.48 | $5.24M | 0 |
| Sep 12, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 62,880 | $117.08 | $7.36M | 0 |
| Sep 5, 2025 | Saad Mark E | Director | Sell | 9,127 | $125.07 | $1.14M | 0 |
| Sep 2, 2025 | JEFFS ROGER | Director | Sell | 13,464 | $123.68 | $1.67M | 0 |
| Aug 27, 2025 | JEFFS ROGER | Director | Sell | 60,000 | $121.72 | $7.30M | 0 |
| Aug 22, 2025 | JEFFS ROGER | Director | Sell | 36,694 | $120.05 | $4.41M | 0 |
| Jun 20, 2025 | Murdock Hunter R. | General Counsel | Sell | 13,514 | $101.42 | $1.37M | 0 |
| Jun 16, 2025 | Murdock Hunter R. | General Counsel | Sell | 22,500 | $101.19 | $2.28M | 0 |
| Jun 9, 2025 | Jacobson Mark L. | Chief Operating Officer | Sell | 25,000 | $110.44 | $2.76M | 0 |
| May 27, 2025 | Coleman Mark | Director | Sell | 7,500 | $104.45 | $783.4K | 0 |
| May 27, 2025 | Jacobson Mark L. | Chief Operating Officer | Sell | 40,673 | $104.07 | $4.23M | 0 |
| May 20, 2025 | Coleman Mark | Director | Sell | 3,000 | $107.49 | $322.5K | 0 |
| Feb 13, 2025 | Pizzie Nick | Chief Financial Officer | Sell | 15,000 | $130.10 | $1.95M | 0 |
| Aug 9, 2024 | Jacobson Mark L. | Chief Operating Officer | Sell | 47,739 | $84.26 | $4.02M | 0 |
| May 29, 2024 | Jacobson Mark L. | Chief Operating Officer | Sell | 7,910 | $74.31 | $587.8K | 0 |
| May 28, 2024 | Coleman Mark | Director | Sell | 10,497 | $75.17 | $789.1K | 0 |
| Apr 1, 2024 | Jacobson Mark L. | Chief Operating Officer | Sell | 24,662 | $77.24 | $1.90M | 0 |
| Mar 14, 2024 | JEFFS ROGER | Director | Sell | 32,323 | $69.84 | $2.26M | 0 |
| Sep 15, 2023 | Coleman Mark | Director | Sell | 29,588 | $75.18 | $2.22M | 0 |
AXSM Insiders
TABUTEAU HERRIOT
director, 10 percent owner, officer: Chief Executive Officer
Sold $110.58M
9 tradesLast: Aug 7, 2026
Similar Stocks to AXSM
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
INCY
Incyte Corporation
$121.65-0.43%
$24.62B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B